PCV55 - Cost-Utility Analysis of Angiotensin Receptor–Neprilysin Inhibitor Sacubitril/Valsartan Compared with Ace Inhibitors for the Treatment of Chronic Heart Failure in the United States
| Autor: | Harrington, RL, Zueger, PM, Kumar, VM, Rigoni, G, Atwood, AM, DiDomenico, RJ, Touchette, DR |
|---|---|
| Zdroj: | In Value in Health May 2016 19(3):A49-A49 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect